Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Pain Due to Osteoarthritis Taking WHO Step III Analgesics But Showing a Lack of Tolerability.

NCT00982280 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

82

Enrollment

INDUSTRY

Sponsor class

Stopped Slow Recruitment and supply of Investigational Medicinal Product Issues

Conditions

Chronic Pain
Osteoarthritis

Interventions

DRUG: Tapentadol PR

Sponsor

Grünenthal GmbH